Chlorpheniramine Maleate is an antihistamine widely utilized to alleviate symptoms associated with allergies, hay fever, and the common cold. Since its introduction in 1951, it has become one of the most commonly used classical antihistamines.
Chemical Structure
Chlorpheniramine Maleate is a complex molecule, notable for its detailed chemical structure.
- Molecular Formula: C20H23ClN2O4
- Molecular Weight: Approximately 390.86 g/mol
- IUPAC Name: 3-(4-Chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine
- Stereochemistry: Chlorpheniramine Maleate is a racemic compound, meaning it contains equal amounts of two enantiomers.
- Solubility: Soluble in water with a solubility of 0.55 g/100 mL.
Its chemical structure includes a pyridine ring connected to a propylamine chain, which is also linked to a chlorophenyl group. For a more comprehensive understanding, a 3D representation of the molecule can be consulted.
Mechanism of Action
Chlorpheniramine Maleate works by competing with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. By blocking the action of endogenous histamine, it provides temporary relief from symptoms caused by histamine.
Pharmacokinetics
- Absorption: Rapidly absorbed into the bloodstream after oral administration, with peak plasma concentration reached within two hours.
- Distribution: While specific distribution data is limited, it is likely distributed throughout the body, particularly in well-perfused organs.
- Metabolism: Extensively metabolized in the liver, though exact pathways are not well documented.
- Excretion: The elimination half-life ranges from 13.9 to 43.4 hours, indicating infrequent dosing may be adequate, especially in adults.
- Bioavailability: Reported to be between 25% and 50%, meaning only a fraction of the orally administered dose reaches systemic circulation.
Individual variations such as age, gender, and liver function can influence these parameters. Consultation with a healthcare provider is recommended for personalized information.
Therapeutic Uses
Chlorpheniramine Maleate is employed to manage various allergic conditions:
- Allergic Rhinitis: Treats both perennial and seasonal allergic rhinitis, alleviating symptoms like runny nose and sneezing.
- Hay Fever: Provides relief from itchy eyes, runny nose, and sneezing associated with hay fever.
- Common Cold: Eases symptoms such as runny nose, sneezing, and watery eyes.
- Allergic Conjunctivitis: Treats conjunctivitis caused by inhalant allergens and foods.
- Urticaria and Angioedema: Manages mild, uncomplicated allergic skin manifestations.
- Dermographism: Used for amelioration of allergic reactions to blood or plasma and dermographism.
While effective in symptom management, Chlorpheniramine Maleate does not cure these conditions.
Chlorpheniramine Maleate Side Effects
Chlorpheniramine Maleate can cause several side effects, which are categorized as common or serious.
- Common Side Effects:
- Drowsiness: Often subsides with prolonged use.
- Dry Mouth: Reduced saliva production.
- Dizziness: Particularly when standing quickly.
- Nausea: Especially if taken on an empty stomach.
- Loss of Appetite: Decrease in appetite.
- Blurred Vision: Less common.
- Nervousness and Excitability: More common in children.
- Disturbance in Attention and Abnormal Coordination: Less common.
- Serious Side Effects:
- Allergic Reaction: Includes rash, hives, itching, swelling, and breathing difficulties.
- Cardiovascular Issues: Palpitations, tachycardia, arrhythmias, and hypotension.
- Gastrointestinal Issues: Vomiting, abdominal pain, diarrhea, and dyspepsia.
- Dermatologic Issues: Exfoliative dermatitis, rash, urticaria, and photosensitivity.
- Psychiatric Issues: Confusion, excitation, irritability, nightmares, and depression.
Seek medical attention if unusual or bothersome symptoms occur.
Drug Interactions
Chlorpheniramine Maleate can interact with various drugs, impacting its efficacy or increasing the risk of side effects.
- Major Interactions: Includes Zafirlukast, requiring changes in therapy or special monitoring.
- Moderate Interactions: Includes Alprazolam, Betahistine, Chlordiazepoxide, and 334 other drugs, potentially requiring dose adjustments or additional monitoring.
- Minor Interactions: Typically not clinically significant but may require monitoring.
Specific Interactions:
- Other Antihistamines: Increases risk of side effects like drowsiness and dry mouth.
- Opioid Pain or Cough Relievers: Heightens risk of drowsiness, dizziness, and concentration difficulties.
- Drugs for Sleep or Anxiety: Similar increased risk of drowsiness and dizziness.
- Muscle Relaxants: Heightened risk of drowsiness and dizziness.
Safety Considerations
Chlorpheniramine Maleate should be used cautiously in individuals with conditions like narrow-angle glaucoma, bladder neck obstruction, urinary retention, prostate hypertrophy, acute asthmatic attacks, stenosing peptic ulcer, and pyloroduodenal obstruction. It is not recommended for premature or term newborns due to a potential link with Sudden Infant Death Syndrome (SIDS). Consult a healthcare provider before use, especially in patients with asthma, lung disease, heart problems, high blood pressure, diabetes, stroke, increased eye pressure, intestinal blockage, ulcers, seizures, overactive thyroid, or during pregnancy or breastfeeding.
Regulatory Status
Chlorpheniramine Maleate is widely available, often over-the-counter (OTC), depending on local regulations. In the United States, it is an OTC medication. However, in some countries, it might require a prescription.
- United States: Available OTC.
- Other Countries: Availability varies, with some requiring a prescription.
In countries like India, its use in children under four is prohibited due to safety concerns.
Contraindications
Chlorpheniramine Maleate has several contraindications:
- Hypersensitivity: Avoid use in individuals hypersensitive to the drug.
- Narrow-Angle Glaucoma: Can worsen this condition.
- Bladder Neck Obstruction and Urinary Retention: May exacerbate these issues.
- Prostate Hypertrophy: Not recommended for men with an enlarged prostate.
- Acute Asthmatic Attacks: Should not be used during an asthma attack.
- Stenosing Peptic Ulcer and Pyloroduodenal Obstruction: Can aggravate these gastrointestinal conditions.
- Premature and Term Newborns: Not recommended due to potential association with SIDS.
Consult a healthcare provider before starting any new medication.
Table: Chlorpheniramine Maleate Overview
| Category | Information |
|---|---|
| Side Effects | Common: Drowsiness, dry mouth, dizziness, nausea, loss of appetite, blurred vision, nervousness, disturbance in attention; Serious: Allergic reaction, cardiovascular issues, gastrointestinal issues, dermatologic issues, psychiatric issues |
| Dosage | Varies based on condition and patient factors; consult healthcare provider |
| Benefits | Alleviates symptoms of allergic rhinitis, hay fever, common cold, allergic conjunctivitis, urticaria, angioedema, dermographism |
| Usage | Oral administration, effective in managing symptoms but not curing conditions |
| Mechanism of Action | Competes with histamine for H1-receptor sites, blocking histamine action to relieve symptoms |
| Pharmacokinetics | Rapid absorption, peak plasma concentration in 2 hours, extensive liver metabolism, half-life 13.9-43.4 hours, bioavailability 25-50% |
| Drug Interactions | Major: Zafirlukast; Moderate: Alprazolam, Betahistine, Chlordiazepoxide, others; Minor: Not clinically significant but may require monitoring |
| Regulatory Status | OTC in the United States, varies in other countries, restricted use in children under four in some regions |
| Contraindications | Hypersensitivity, narrow-angle glaucoma, bladder neck obstruction, urinary retention, prostate hypertrophy, acute asthma attacks, stenosing peptic ulcer, pyloroduodenal obstruction, premature and term newborns |
Chlorpheniramine Maleate is a valuable medication for managing allergic symptoms but should be used responsibly and under the guidance of a healthcare provider.
